sIL-24 peptide, a human interleukin-24 isoform, induces mitochondrial-mediated apoptosis in human cancer cells
Cancer Chemotherapy and Pharmacology Sep 04, 2017
Valiyari S, et al. – Researchers undertook an investigation and examined the cytotoxic properties of a recombinant smallest isoform of interleukin-24 (IL-24) (sIL–24) and the underlying molecular mechanisms in PC–3, A549, U937, and Raji cancer cells as well as normal cell line MRC–5. For potential treatment of human cancers, the sIL–24 peptide outlined as a promising candidate.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty -
Paid Market Research Surveys -
Case discussions, News & Journals' summaries
